WASHINGTON, Sept. 12, 2018 /PRNewswire/ — Evolent Health, Inc. (NYSE : EVH ) – Evolent Health, Inc. (“Evolent”) and NCIS Holdings, Inc. and New Century Investment, LLC (“New Century Health”) announced today that they have entered into a definitive agreement for Evolent to acquire New Century Health’s business for up …
Tag Archives: Specialty Pharmacy
September, 2018
May, 2018
-
1 May
Diplomat Launches CastiaRx, Industry-Leading Specialty Benefit Manager
FLINT, Mich., April 30, 2018 /PRNewswire/ — Diplomat Pharmacy, Inc. (NYSE: DPLO), has unveiled CastiaRx to respond to industry demand for a leader in specialty benefit management. CastiaRx unites the full-service pharmacy benefit manager (PBM) capabilities of recently acquired LDI Integrated Pharmacy Services and National Pharmaceutical Services with Diplomat’s specialty …
April, 2018
-
27 April
Endo to Acquire Specialty Pharmaceutical Company Somerset Therapeutics for $190 Million
DUBLIN, April 26, 2018 /PRNewswire/ — Endo International plc (NASDAQ: ENDP) today announced that it has reached definitive agreements to acquire Somerset Therapeutics, LLC, a New Jersey based specialty pharmaceutical company that develops and markets sterile injectable and ophthalmic drugs for the U.S. marketplace, and the business of its India based affiliate Wintac Limited, which operates as Somerset Therapeutics’ contract …
December, 2017
-
4 December
CVS Health to Acquire Health Insurer Aetna for $69 Billion
WOONSOCKET, R.I. and HARTFORD, Conn., Dec. 3, 2017 /PRNewswire/ — CVS Health (NYSE: CVS), a company at the forefront of changing the health care landscape, and Aetna (NYSE: AET), one of the nation’s leading diversified health care benefits companies, today announced the execution of a definitive merger agreement under which CVS Health will acquire …
September, 2017
-
27 September
FDA Commissioner Gottlieb on New Efforts to Encourage Compounding of Better Quality Drugs Under DQSA
As a physician, I understand how important it is for health care providers to have access to compounded drugs when the needs of their patients cannot be met by FDA-approved drugs. Our commitment to implementing and enforcing the Drug Quality and Security Act (DQSA) provides a pivotal foundation for achieving …
May, 2017
-
31 May
Albertsons Expands Specialty Services through Acquisition of MedCart Specialty Pharmacy
BOISE, Idaho, May 31, 2017 /PRNewswire/ — Albertsons Companies announced today that it recently acquired MedCart Specialty Pharmacy in order to strengthen and extend its pharmacy specialty services. MedCart Specialty Pharmacy is an industry-leading, URAC accredited, pharmaceutical and healthcare provider of customized specialty care services and medication management for patients …
-
5 May
US Drug Spending Growth of 4.8 Percent in 2016 According to QuintilesIMS Institute Study
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Growth in U.S. spending on prescription medicines fell in 2016 as competition intensified among manufacturers, and payers ramped up efforts to limit price increases, according to research released today by the QuintilesIMS Institute. New medicines introduced in the past two years continue to …
February, 2017
-
6 February
Express Scripts Fights Back Against Irresponsible Drug Pricing
LOUIS, Feb. 6, 2017 /PRNewswire/ — Express Scripts’ (NASDAQ: ESRX) efforts to put medicine within reach for payers and patients effectively held the 2016 growth rate in prescription drug spending to just 3.8 percent – a 27 percent decrease from 2015 – according to the 21st edition of its annual …
December, 2016
-
8 December
ValueCentric Announces Collaboration with Universal Patient Key (UPK) to Enhance Specialty Data De-Identification Capabilities
Adding a key component to their single-provider approach to Specialty data management and analytics ORCHARD PARK, NY — 6 December, 2016 – ValueCentric, a leading provider of data management and analytic solutions to the healthcare industry, today announced a collaboration with Universal Patient Key (UPK), a premier HIPAA compliant de-identification …
-
6 December
Global Drug Market will Reach Nearly $1.5 Trillion in 2021 as Spending Growth Moderates
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Total spending on medicines is forecast to reach $1.5 trillion by 2021, up 33 percent from 2016 levels, even as annual growth moderates from the record pace set in 2014 and 2015, according to new research released today by the QuintilesIMS Institute. While …